BlackRock Investment Management, LLC - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 14 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q4 2016$56,000
+21.7%
6,590
-3.1%
0.00%
Q3 2016$46,000
+170.6%
6,803
+17.0%
0.00%
Q2 2016$17,000
+183.3%
5,815
+87.5%
0.00%
Q1 2016$6,000
+20.0%
3,1020.0%0.00%
Q4 2015$5,0000.0%3,1020.0%0.00%
Q3 2015$5,000
-50.0%
3,1020.0%0.00%
Q2 2015$10,0003,1020.00%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q2 2015
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 2,563,925$16,717,00029.31%
Cormorant Asset Management, LP 2,000,000$13,580,0001.50%
Perceptive Advisors 2,701,023$18,339,0001.18%
Fosun International Ltd 700,071$4,753,0000.53%
Ghost Tree Capital, LLC 200,000$1,358,0000.22%
ACUTA CAPITAL PARTNERS, LLC 81,302$552,0000.21%
IFP Advisors, Inc 300,000$2,037,0000.11%
CONNING INC. 351,280$2,385,0000.10%
WOODSTOCK CORP 39,931$271,0000.06%
Yellowstone Partners, LLC 15,944$108,0000.04%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders